Between 2011 and 2022, the number of issuers fell some in the large-employer market and more in the small-employer market, according to the Government Accountability Office.

A pharmacy group says compounding the two GLP-1 agonists, now commercially available, is not that hard.

Hair loss medications will cost $16 per month, and erectile dysfunction medications will cost $19 per month.

The Paragon Health Institute authors could be on short lists for Trump administration posts.

PhRMA's “Middleman” and “Your Insurance” characters snatch savings away from a bewildered patient.

The American Medical Association plans to seek a federal ban on post-service coverage denials for pre-certified care.

One of the hot GLP-1 agonists will lose its patent protection in the United States in just eight years.

The agency estimates a House AHP measure would add $2.9 billion to the federal budget deficit over 10 years.